Quality control results were reported as ok when a precision run was done.A review of the ldh qc results for (b)(6) to (b)(6) 2019 show within control assay precision.No atypical complaint trends or non-conformance were identified related for the ldh assay results.The ldh assay package insert has extensive information on the need for correct sample preparation.For plasma samples, sufficient centrifugation is necessary to remove platelets and other cellular materials that may impact ldh results.Plasma samples may benefit from the 1:3 dilution provided in the assay parameter file to help decrease the impact of platelets on ldh analyses.To optimize plasma analysis, the package insert states samples may be transferred to a secondary sample tube after centrifugation.Based on the complaint information and the package insert labeling, the most likely cause for the initially elevated ldh results are related to the sample preparation process.The labeling describes cellular debris or platelets as having a likely impact to patient results.With qc material lacking these components, there would be no impact on those samples.Use error may have contributed to the customer issue as insufficient sample collection or preparation is a likely cause of the initially elevated sample results.Trend review and lot search did not identify an increase in complaint activity for the current issue.No customer returns were available for evaluation.No product deficiency was identified.
|